Staar Surgical price to free cash flow STAA

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 31.6×; Feb 2025
9-year median: 157×
9-year range: 28.8× to 497×
Peer median: 18.8×

Staar Surgical's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Feb 2025, at 31.6×.

On the days it had one over the last 9 years, its median was 157×, from 28.8× in Feb 2025 to 497× in Apr 2021.

Price to free cash flow over time

median 156.8×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	31.6×	28.8×	46.0×
2024	45.4×	45.4×	139×
2023	159×	129×	194×
2022	104×	71.8×	226×
2021	99.0×	96.9×	497×
2020	385×	74.8×	408×
2019	153×	126×	185×
2018	142×	135×	436×
2017	473×	418×	496×
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	n/m a value too high to mean anything
2013	257×	85.8×	257×
2012	95.1×	85.1×	133×

Against its peers

Companies in Medical - Instruments & Supplies nearest Staar Surgical's size, closest first, today.

Company	Price to free cash flow
STAAStaar Surgical	n/m
IRMDIradimed	43.7×
BVSBioventus	13.3×
CDRECadre	16.4×
EYENational Vision	30.1×
MOVMovado	9.8×
LMATLemaitre Vascular	26.2×
INSPInspire Medical Systems	17.6×
MDXGMimedx	n/m
UFPTUFP Technologies	n/m
TCMDTactile Systems Technology	20.0×
Peer median	18.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Staar Surgical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.